{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T19:06:50Z","timestamp":1784833610572,"version":"3.55.0"},"reference-count":33,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T00:00:00Z","timestamp":1772841600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Viruses"],"abstract":"<jats:p>Epstein\u2013Barr virus (EBV), a ubiquitous human herpesvirus infecting over 90% of the adult population, is causally associated with a distinct molecular subtype of gastric cancer (GC). A key mechanism by which EBV influences tumour biology is the expression of viral microRNAs (miR\/miRNA) encoded within the BamHI-A rightward transcript (BART) region, although inter-patient variability in EBV-miRNA expression and its molecular significance remain incompletely defined. In this study, small RNA sequencing was performed on 11 primary gastric tumour samples to characterise EBV-derived miRNA expression, followed by quantitative RT-PCR analysis in an extended cohort of 21 tumours for targeted validation. EBV-miRNAs were detected in a subset of tumours and showed marked inter-tumour heterogeneity in abundance. EBV-miRNA-positive tumours were dominated by a conserved set of BART miRNAs, including miR-BART19-3p, miR-BART1-5p, miR-BART10-3p, miR-BART6-3p, miR-BART13-5p, and miR-BART22. These BART miRNAs displayed correlated expression patterns, characterised by concurrent elevation of multiple viral miRNA species within the same tumour samples. To link viral miRNA expression with host molecular responses, in silico virus\u2013host interaction analysis was conducted using ViRBase to prioritise host genes associated with the detected BART miRNAs. PTEN, BCL2L11, FOXO3, and CDKN1A were identified as high-confidence targets and selected for experimental assessment. RT-qPCR analysis demonstrated differential expression of these host genes across tumours stratified by EBV BART miRNA abundance. Together, these findings identify a consistent BART miRNA pattern within this cohort. This study provides patient-level molecular evidence linking EBV-miRNA regulatory output to host gene expression states in GC.<\/jats:p>","DOI":"10.3390\/v18030329","type":"journal-article","created":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T11:06:52Z","timestamp":1773054412000},"page":"329","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["EBV BART microRNA Profiles and Host Gene Links in Gastric Cancer"],"prefix":"10.3390","volume":"18","author":[{"given":"Esra","family":"Dirimtekin","sequence":"first","affiliation":[{"name":"Department of Medical Genetics, School of Medicine, Marmara University, 34854 Istanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3801-8583","authenticated-orcid":false,"given":"D. Alwyn","family":"Dart","sequence":"additional","affiliation":[{"name":"UCL Cancer Institute, University College London, Paul O\u2019Gorman Building, 72 Huntley Street, London WC1E 6DD, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3190-8831","authenticated-orcid":false,"given":"Pinar","family":"Uysal-Onganer","sequence":"additional","affiliation":[{"name":"Cancer Mechanisms and Biomarkers Research Group, School of Life Sciences, University of Westminster, London W1W 6UW, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,3,7]]},"reference":[{"key":"ref_1","first-page":"209","article-title":"Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/S0140-6736(20)31288-5","article-title":"Gastric cancer","volume":"396","author":"Smyth","year":"2020","journal-title":"Lancet"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/nature13480","article-title":"Comprehensive molecular characterization of gastric adenocarcinoma","volume":"513","author":"Bass","year":"2014","journal-title":"Nature"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1038\/nm.3850","article-title":"Molecular analysis of gastric cancer identifies subtypes associated with distinct clinical outcomes","volume":"21","author":"Cristescu","year":"2015","journal-title":"Nat. Med."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Liu, T., Zhou, X., Zhang, Z., Qin, Y., Wang, R., Qin, Y., Huang, Y., Mo, Y., and Huang, T. (2023). The role of EBV-encoded miRNA in EBV-associated gastric cancer. Front. Oncol., 13.","DOI":"10.3389\/fonc.2023.1204030"},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Kincaid, R.P., and Sullivan, C.S. (2012). Virus-encoded microRNAs: An overview and a look to the future. PLoS Pathog., 8.","DOI":"10.1371\/journal.ppat.1003018"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/ni.2537","article-title":"MicroRNAs as mediators of viral evasion of the immune system","volume":"14","author":"Cullen","year":"2013","journal-title":"Nat. Immunol."},{"key":"ref_8","first-page":"181","article-title":"EBV Noncoding RNAs","volume":"391","author":"Skalsky","year":"2015","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1038\/s41392-023-01622-1","article-title":"Dynamic single-cell mapping unveils Epstein-Barr virus-imprinted T-cell exhaustion and on-treatment response","volume":"8","author":"Qiu","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1084\/jem.20072581","article-title":"An Epstein-Barr virus-encoded microRNA targets PUMA to promote host cell survival","volume":"205","author":"Choy","year":"2008","journal-title":"J. Exp. Med."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.3892\/ijo.2015.2856","article-title":"Update on Epstein-Barr virus and gastric cancer (review)","volume":"46","author":"Kunita","year":"2015","journal-title":"Int. J. Oncol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"4719","DOI":"10.1158\/0008-5472.CAN-09-4620","article-title":"Downregulation of MicroRNA-200 in EBV-Associated Gastric Carcinoma","volume":"70","author":"Shinozaki","year":"2010","journal-title":"Cancer Res."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1593\/neo.09888","article-title":"Modulation of LMP2A expression by a newly identified Epstein-Barr virus-encoded microRNA miR-BART22","volume":"11","author":"Lung","year":"2009","journal-title":"Neoplasia"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"2918","DOI":"10.1182\/bloodadvances.2020001451","article-title":"Nationwide survey of systemic chronic active EBV infection in Japan in accordance with the new WHO classification","volume":"4","author":"Yonese","year":"2020","journal-title":"Blood Adv."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"5222","DOI":"10.1128\/JVI.03614-14","article-title":"Genome diversity of Epstein-Barr virus from multiple tumor types and normal infection","volume":"89","author":"Palser","year":"2015","journal-title":"J. Virol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"e01132-18","DOI":"10.1128\/JVI.01132-18","article-title":"Sequence Variation of Epstein-Barr Virus: Viral Types, Geography, Codon Usage, and Diseases","volume":"92","author":"Correia","year":"2018","journal-title":"J. Virol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.bbrc.2017.10.095","article-title":"EBV-encoded EBNA1 regulates cell viability by modulating miR34a-NOX2-ROS signaling in gastric cancer cells","volume":"494","author":"Kim","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Li, R., Liao, G., Nirujogi, R.S., Pinto, S.M., Shaw, P.G., Huang, T.-C., Wan, J., Qian, J., Gowda, H., and Wu, X. (2016). Phosphoproteomic Profiling Reveals Epstein-Barr Virus Protein Kinase Integration of DNA Damage Response and Mitotic Signaling. PLoS Pathog., 11.","DOI":"10.1371\/journal.ppat.1005346"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"D928","DOI":"10.1093\/nar\/gkab1029","article-title":"ViRBase v3.0: A virus and host ncRNA-associated interaction repository with increased coverage and annotation","volume":"50","author":"Cheng","year":"2022","journal-title":"Nucleic Acids Res."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"12092","DOI":"10.1093\/nar\/gkad936","article-title":"The three-dimensional structure of the EBV genome plays a crucial role in regulating viral gene expression in EBVaGC","volume":"51","author":"Maestri","year":"2023","journal-title":"Nucleic Acids Res."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1099\/vir.0.006551-0","article-title":"Epstein-Barr virus BART gene expression","volume":"90","author":"Bodelon","year":"2009","journal-title":"J. Gen. Virol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"e00375-17","DOI":"10.1128\/JVI.00375-17","article-title":"Natural Variation of Epstein-Barr Virus Genes, Proteins, and Primary MicroRNA","volume":"91","author":"Correia","year":"2017","journal-title":"J. Virol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/nrc1452","article-title":"Epstein\u2013Barr virus: 40 years on","volume":"4","author":"Young","year":"2004","journal-title":"Nat. Rev. Cancer"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/bjc.2011.215","article-title":"Determinants of Epstein-Barr virus-positive gastric cancer: An international pooled analysis","volume":"105","author":"Camargo","year":"2011","journal-title":"Br. J. Cancer"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1007\/s13402-020-00538-0","article-title":"EBV-miR-BART10-3p and EBV-miR-BART22 promote metastasis of EBV-associated gastric carcinoma by activating the canonical Wnt signaling pathway","volume":"43","author":"Dong","year":"2020","journal-title":"Cell. Oncol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1159\/000479749","article-title":"Epstein-Barr Virus miR-BART6-3p Inhibits the RIG-I Pathway","volume":"9","author":"Lu","year":"2017","journal-title":"J. Innate Immun."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"5217039","DOI":"10.1155\/2020\/5217039","article-title":"The Oncogenic Role of miR-BART19-3p in Epstein-Barr Virus-Associated Diseases","volume":"2020","author":"Zhang","year":"2020","journal-title":"Biomed. Res. Int."},{"key":"ref_28","first-page":"2125","article-title":"Expression and significance of EBV, ARID1A and PIK3CA in gastric carcinoma","volume":"19","author":"Zhou","year":"2019","journal-title":"Mol. Med. Rep."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"2766","DOI":"10.1158\/0008-5472.CAN-08-3070","article-title":"Activation of DNA Methyltransferase 1 by EBV Latent Membrane Protein 2A Leads to Promoter Hypermethylation of PTEN Gene in Gastric Carcinoma","volume":"69","author":"Hino","year":"2009","journal-title":"Cancer Res."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.virol.2011.01.028","article-title":"The Epstein-Barr Virus BART microRNAs target the pro-apoptotic protein Bim","volume":"412","author":"Marquitz","year":"2011","journal-title":"Virology"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1086\/590502","article-title":"A new humanized mouse model of Epstein-Barr virus infection that reproduces persistent infection, lymphoproliferative disorder, and cell-mediated and humoral immune responses","volume":"198","author":"Yajima","year":"2008","journal-title":"J. Infect. Dis."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"177","DOI":"10.5230\/jgc.2025.25.e4","article-title":"PD-L1 as a Biomarker in Gastric Cancer Immunotherapy","volume":"25","author":"Cho","year":"2025","journal-title":"J. Gastric Cancer"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1038\/s41591-018-0101-z","article-title":"Comprehensive molecular characterization of clinical responses to PD-1 inhibition in metastatic gastric cancer","volume":"24","author":"Kim","year":"2018","journal-title":"Nat. Med."}],"container-title":["Viruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4915\/18\/3\/329\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T11:08:22Z","timestamp":1773054502000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4915\/18\/3\/329"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,7]]},"references-count":33,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,3]]}},"alternative-id":["v18030329"],"URL":"https:\/\/doi.org\/10.3390\/v18030329","relation":{},"ISSN":["1999-4915"],"issn-type":[{"value":"1999-4915","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,7]]}}}